Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEEEN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,491
Award facts
- Contract value 100% obligated
- $33,491.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,491.48 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 2, 2025, with completion by December 3, 2025, represents a pharmaceutical supply purchase under the company's broader Indefinite Delivery Contract (IDC) established through the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V is a $30.3 billion DLA acquisition strategy designed to streamline pharmaceutical supply chains across the Department of Defense's global military healthcare operations. No set-aside designation was applied to this award, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group serves as a critical regional prime vendor contractor within the PPV-G GEN V framework, with authorization to supply an extensive portfolio of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities worldwide. The company's IDC, valued at $499,999,999 through December 31, 2036, provides the contractual vehicle for the Defense Logistics Agency to issue firm fixed-price delivery orders for recurring pharmaceutical needs. DMS Pharmaceutical Group has demonstrated consistent performance across multiple delivery orders issued between October and December 2025, supplying critical medications ranging from emergency treatments to specialty oncology and immunosuppressant products, positioning the company as a key supplier within the Department of Defense's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DU26FEEEN?
SPE2DU26FEEEN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DU26FEEEN worth?
The government has obligated $33,491 on SPE2DU26FEEEN.
Is contract SPE2DU26FEEEN an order under another contract?
Yes. SPE2DU26FEEEN is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEEN competed?
The extent of competition for SPE2DU26FEEEN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award